Close Menu

How's this for belt-tightening? The Wall Street Journal reports that GlaxoSmithKline has announced it will "no longer use corporate funds for political contributions as part of an effort to improve openness in its business," according to the article. The company donated more than $585,000 in the US this year. (The company adopted this same policy in Europe in 2001.) No word, though, on whether that money will be redirected to R&D.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.